Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: A multi-stage, randomised, double-blind, placebo-controlled trial

  • Ceftriaxone Study Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1083-1091
Number of pages9
JournalThe Lancet Neurology
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Keywords

  • Adult
  • Aged
  • Amyotrophic Lateral Sclerosis/diagnosis
  • Ceftriaxone/adverse effects
  • Double-Blind Method
  • Dyspnea/chemically induced
  • Female
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome

Cite this